Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Tursz

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Plos One|March 26, 2009
Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15RalphaSophie Viaud, Magali Terme, Caroline Flament, et al.
Clinical Breast Cancer|December 31, 2005
Dermal lymphatic emboli in inflammatory and noninflammatory breast cancer: a French-Tunisian joint study in 337 patientsMonique G Lê, Rodrigo Arriagada, Genèvieve Contesso, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2010
Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: a critical role of interferon-γSophie Viaud, Stéphanie Ploix, Valérie Lapierre, et al.
Molecular Oncology|August 6, 2013
A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrencesLorenza Mittempergher, Mahasti Saghatchian, Denise M Wolf, et al.
Immunological Reviews|November 6, 2007
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapyLionel Apetoh, François Ghiringhelli, Antoine Tesniere, et al.
Tumori|June 21, 2008
Improvement of European translational cancer research. Collaboration between comprehensive cancer centersUlrik Ringborg, Dominique de Valeriola, Wim van Harten, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cellsFabrice André, Nathalie Chaput, Nöel E C Schartz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Gap junction communication between autologous endothelial and tumor cells induce cross-recognition and elimination by specific CTLHoussem Benlalam, Abdelali Jalil, Meriem Hasmim, et al.
Lancet (London, England)|July 31, 2002
Malignant effusions and immunogenic tumour-derived exosomesFabrice Andre, Noel E C Schartz, Mojgan Movassagh, et al.
Journal of Oncology Practice|August 14, 2014
Pioneering quality assessment in European cancer centers: a data analysis of the organization for European cancer institutes accreditation and designation programMahasti Saghatchian, Frédérique Thonon, Femke Boomsma, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Plos One|March 26, 2009
Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15RalphaSophie Viaud, Magali Terme, Caroline Flament, et al.
Clinical Breast Cancer|December 31, 2005
Dermal lymphatic emboli in inflammatory and noninflammatory breast cancer: a French-Tunisian joint study in 337 patientsMonique G Lê, Rodrigo Arriagada, Genèvieve Contesso, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2010
Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: a critical role of interferon-γSophie Viaud, Stéphanie Ploix, Valérie Lapierre, et al.
Molecular Oncology|August 6, 2013
A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrencesLorenza Mittempergher, Mahasti Saghatchian, Denise M Wolf, et al.
Immunological Reviews|November 6, 2007
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapyLionel Apetoh, François Ghiringhelli, Antoine Tesniere, et al.
Tumori|June 21, 2008
Improvement of European translational cancer research. Collaboration between comprehensive cancer centersUlrik Ringborg, Dominique de Valeriola, Wim van Harten, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cellsFabrice André, Nathalie Chaput, Nöel E C Schartz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Gap junction communication between autologous endothelial and tumor cells induce cross-recognition and elimination by specific CTLHoussem Benlalam, Abdelali Jalil, Meriem Hasmim, et al.
Lancet (London, England)|July 31, 2002
Malignant effusions and immunogenic tumour-derived exosomesFabrice Andre, Noel E C Schartz, Mojgan Movassagh, et al.
Journal of Oncology Practice|August 14, 2014
Pioneering quality assessment in European cancer centers: a data analysis of the organization for European cancer institutes accreditation and designation programMahasti Saghatchian, Frédérique Thonon, Femke Boomsma, et al.
Pageof 5